Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
10/09/2013 | EP2646023A1 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
10/09/2013 | EP2646022A1 Novel phenyl oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
10/09/2013 | EP2646021A1 Oxadiazole derivatives as sphingosine 1-phosphate (s1p)receptor modulators |
10/09/2013 | EP2646018A1 Novel oxime azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
10/09/2013 | EP2646013A2 Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
10/09/2013 | EP2646007A2 Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof |
10/09/2013 | CN103347872A Bicyclic compound |
10/09/2013 | CN103347860A Nampt抑制剂 Nampt inhibitor |
10/09/2013 | CN103347856A Multifunctional nitroxide derivatives and uses thereof |
10/09/2013 | CN103347565A Composition and method for treating ocular edema, neovascularization and related disease |
10/09/2013 | CN103347516A Novel inhibitors of matrix metalloproteinases |
10/09/2013 | CN103347513A Use of (s) - esmolol for controlling venous irritation associated with the treatment of a cardiac disorder |
10/09/2013 | CN103347508A Methods of treatment using lipid compound |
10/09/2013 | CN103342759A Novel biological material with controlled release of nitrogen monoxide under catalysis of enzyme, as well as preparation method and application thereof |
10/09/2013 | CN103342757A Amphipathic chondroitin sulfate derivative and preparation method and application thereof |
10/09/2013 | CN103342744A Angiogenesis protein and application thereof |
10/09/2013 | CN103342729A Caffeoyl substituted pentacyclic triterpenoid derivatives and purpose thereof |
10/09/2013 | CN103342700A 11[beta]-hydroxysteroid dehydrogenase type 1 inhibitor |
10/09/2013 | CN103342696A Substituted dihydropyrazolon for treating cardiovascular and haematological diseases |
10/09/2013 | CN103342695A 1',3'-disubstituted-4-pheny-3,4,5,6-tetrahydro-2H,1'H-[1,4']bipyridinyl-2'-ones |
10/09/2013 | CN103342680A Benzazepine derivatives useful as vasopressin antagonists |
10/09/2013 | CN103342679A Benzazepine derivatives useful as vasopressin antagonists |
10/09/2013 | CN103341174A Method for screening pulsatile sustained release material used for Xuesaitong (name of Chinese medicine) medicine |
10/09/2013 | CN103341159A Application of immune regulation markers TIPE2 (Tumor Necrosis Factor-a Induced Protein 8 like 2) in preparation of medicine used for treating vascular proliferation diseases |
10/09/2013 | CN103341158A Application of beta-arrestin-1 to preparation of drugs for preventing and treating ischemia-induced nerve injury diseases |
10/09/2013 | CN103341156A Recombinant anti-hypertension peptide enteric-coated nanoparticles as well as preparation method and application thereof |
10/09/2013 | CN103341155A Stable compound coenzyme preparation and preparation method as well as application thereof |
10/09/2013 | CN103341153A Traditional Chinese medicine composition for treating raynaud disease |
10/09/2013 | CN103341124A Traditional Chinese medicine for treating cardiac neurosis |
10/09/2013 | CN103341120A Purely Chinese herbal preparation for reducing blood pressure |
10/09/2013 | CN103341116A Medicine for treating heart pain and preparation method thereof |
10/09/2013 | CN103341082A Application of Chinese medicine composition in preparation of medicine used for treating hypertension and proteinuria |
10/09/2013 | CN103341081A Traditional Chinese medicine composition for treating hypertension and proteinuria |
10/09/2013 | CN103341070A Externally used medicine for preventing and treating hypertension, hyperlipidemia, hyperglycemia and hypotension and preparation method thereof |
10/09/2013 | CN103341069A Tibetan medicament for treating angina pectoris and preparation method thereof |
10/09/2013 | CN103341054A Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
10/09/2013 | CN103341053A Purification method for large ligusticum wallichii oral liquid |
10/09/2013 | CN103341052A Medicine for preventing and treating hypertension, hyperlipidemia, hyperglycemia and hypotension and preparation method thereof |
10/09/2013 | CN103341049A Dendrobium huoshanense-containing traditional Chinese medicine composition with anti-fatigue effect, and preparation method thereof |
10/09/2013 | CN103341040A Traditional Chinese medicine for treating constrictive pericarditis |
10/09/2013 | CN103341031A Spraying agent for relieving angina |
10/09/2013 | CN103341015A Medicine for treating three-highs and preparation method thereof |
10/09/2013 | CN103340998A Hand tremble rehabilitation capsules |
10/09/2013 | CN103340985A Medicine for reducing blood pressure and treating arthromyodynia |
10/09/2013 | CN103340951A Traditional Chinese medicine used for preventing and treating cerebral thrombosis and preparation method thereof |
10/09/2013 | CN103340933A Traditional Chinese medicine composition and application thereof in atherosclerosis treatment |
10/09/2013 | CN103340919A Lucid ganoderma refined powder compound soft capsule and preparation method thereof |
10/09/2013 | CN103340916A Lindley eupatorium extract as well as preparation method and application thereof |
10/09/2013 | CN103340902A Composition containing cardiogenic factors, associated method, cell, and applications of composition, method and cell |
10/09/2013 | CN103340890A Application of NADPH in preparing medicaments for preventing and treating ischemic cerebral stroke |
10/09/2013 | CN103340888A Application of Polyflavanostilbene A in preparation of medicine for treating ischemic brain injury |
10/09/2013 | CN103340886A Application of Polyflavanostilbene A in preparation of medicine for treating myocardial ischemia |
10/09/2013 | CN103340860A Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy |
10/09/2013 | CN103340851A Use of columbin in preparation of drug for treating cerebral ischemia |
10/09/2013 | CN103340849A Application of naringenin in preparing medicament for preventing and/or treating abdominal aortic aneurysm |
10/09/2013 | CN103340846A Arachidonic acid soft capsule and preparation method |
10/09/2013 | CN103340844A Application of gamatine in preparing drug resisting high PTH |
10/09/2013 | CN103340842A Nimodipine film agent for oral cavities and preparation method of nimodipine film agent |
10/09/2013 | CN103340839A Preparation method of earthworm fibrinolytic modified enzyme chitosan enteric microsphere capsule |
10/09/2013 | CN103340836A Panax notoginoside pulsatile controlled release tablet prescription and preparation method thereof |
10/09/2013 | CN102935170B Chinese medicament for treating suppurative pylephlebitis |
10/09/2013 | CN102876553B Preparation method of high-quality mung bean liquor |
10/09/2013 | CN102863457B Optically-active 2- hydroxyltetrathienopyridine derivative, preparation method thereof and application of optically-active 2- hydroxyltetrathienopyridine derivative to pharmacy |
10/09/2013 | CN102805809B Oral liquid for treating infant myocarditis |
10/09/2013 | CN102755626B Traditional Chinese medicine combination for treating sinus sick syndrome and preparation method |
10/09/2013 | CN102716130B Transformable acupoint injection ligustrazine medicine and method for preparing same |
10/09/2013 | CN102698049B Crude rehmannia root Chinese medicinal decoction for treating palpitation and preparation method thereof |
10/09/2013 | CN102641253B Valsartan sustained release tablet and preparation method thereof |
10/09/2013 | CN102438625B Pharmaceutical composition for neuroprotective treatment in patients with ictus comprising citicoline and uric acid |
10/09/2013 | CN102423352B Preparation method of Chinese medicinal granules for treating cardio-cerebrovascular diseases |
10/09/2013 | CN102266569B Application of miR-199a and inhibitor thereof |
10/09/2013 | CN102204917B Pharmaceutical composition containing fasudil and sildenafil, and preparation method and application thereof |
10/09/2013 | CN102061322B Method for preparing polysaccharide, flavone and dietary fiber of peanut hulls in united manner |
10/09/2013 | CN101659649B Novel epigallocatechin gallate tetramer, and vascular endothelial function improver comprising same |
10/08/2013 | US8552196 Apoptosis signal-regulating kinase inhibitors |
10/08/2013 | US8552149 Polypeptides and use thereof |
10/08/2013 | US8552062 Methods for the treatment of metabolic disorders such as diabetes |
10/08/2013 | US8552054 Anticancer agents, viricides, psychological disorders |
10/08/2013 | US8552040 Isoxazoline compounds having MIF antagonist activity |
10/08/2013 | US8552023 Non-amidic linkers with branched termini as CGRP receptor antagonists |
10/08/2013 | US8552013 Heterocyclic compounds based on N6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
10/08/2013 | US8551992 Aminooxazole inhibitors of cyclin dependent kinases |
10/08/2013 | US8551947 Treatment of hibernating myocardium with an exendin peptide |
10/08/2013 | US8551521 Stable pharmaceutical composition and methods of using same |
10/08/2013 | CA2750089C Novel method for the synthesis of ivabradine and the pharmaceutically acceptable acid addition salts thereof |
10/08/2013 | CA2647501C Use of cholest-4-in-3-in-one derivatives to obtain a cytoprotective medicine |
10/08/2013 | CA2473938C Human adam-10 inhibitors |
10/03/2013 | WO2013149258A2 Compositions and methods for treating or preventing metabolic syndrome disorders |
10/03/2013 | WO2013148768A1 Crystalline forms of (r)-3-[n-(3'-chlorobiphenyl-4-ylmethyl)-n'-(3-hydroxyisoxazole-5-carbonyl)hydrazino]-2-hydroxypropionic acid isopropyl ester |
10/03/2013 | WO2013148603A1 Cinnoline derivatives as as btk inhibitors |
10/03/2013 | WO2013148405A2 Treatment for atherosclerosis |
10/03/2013 | WO2013148136A1 Omega-3 fatty acid ester compositions |
10/03/2013 | WO2013148122A1 Methods and compositions using fgf-9 to enchance neovascularization and regeneration |
10/03/2013 | WO2013147161A1 Nipecotic acid derivative and use thereof for medical purposes |
10/03/2013 | WO2013147137A1 Therapeutic agent for cardiac failure |
10/03/2013 | WO2013147135A1 Controlled-release pharmaceutical composition |
10/03/2013 | WO2013147117A1 Fused azole derivative |
10/03/2013 | WO2013147082A1 Immortalized stem cells and medicinal composition and medicinal preparation comprising product thereof as active ingredient |
10/03/2013 | WO2013147076A1 FIBROSIS SUPPRESSION BY INHIBITING INTEGRIN α8β1 FUNCTION |
10/03/2013 | WO2013146970A1 Novel quinoline derivative |